Method of measuring insulin resistance with fatty acid combustion, and composition used herein
This invention provides a method for measuring insulin resistance of a test subject, and a composition suitably used for the method. A method for measuring insulin resistance of a test act comprising steps (a) and (b) below, the method using a composition for measuring insulin resistance comprising, as an active ingredient, a C 12-38 fatty acid labeled with at least one isotope of C, wherein the C 12-38 fatty acid is converted in the body into labeled carbon dioxide that is excreted in expired air, (a) intravenously administering the composition to a test subject and collecting expired air; and (b) determining the ratio of labeled CO 2 amount to unlabeled CO 2 amount contained in the expired air or the ratio of labeled CO 2 amount to total CO 2 amount contained in the expired air.
1. A method for measuring insulin resistance of a test subject, comprising
determining an area under a Δ-labeled C(‰)-expired air collection time t curve, based on a glucose metabolism ability measurement method having steps (i) and (ii) below (hereinafter referred to as “AUCt[labeled C-glucose]”),
determining an area under a Δ-labeled C(‰)-expired air collection time t curve, based on a method having steps (a) and (b) below (hereinafter referred to as “AUCt[labeled C-fatty acid]”),
using a value obtained by dividing the AUCt[labeled C-glucose] by the AUCt[labeled C-fatty acid] (AUCt[labeled C-glucose]/AUCt[labeled C-fatty acid]) as an index for the sugar/fatty acid combustion ratio,
determining a first index of the sugar/fatty acid combustion ratio under a fasting condition and a second index of the sugar/fatty acid combustion ratio under a feeding condition from the test subject, and
determining a difference between the first index and the second index, wherein the test subject's insulin resistance is measured,
wherein
the method in which AUCt[labeled C-glucose] is determined has the steps of:
(i) intravenously administering a composition to a test subject and collecting expired air, the composition comprising, as an active ingredient, glucose labeled with at least one isotope of carbon, so that the glucose is converted in the body into labeled carbon dioxide that is excreted in expired air; and
(ii) determining the ratio of labeled CO 2 amount to unlabeled CO 2 amount contained in expired air or the ratio of labeled CO 2 amount to total CO 2 amount contained in expired air, and
the method in which AUCt[labeled C-fatty acid] is determined has the steps of:
(a) intravenously administering a composition comprising a C 12-38 fatty acid or a salt thereof labeled with at least one isotope of carbon to a test subject and collecting expired air, so that the C 12-38 fatty acid or salt thereof is converted in the body into labeled carbon dioxide that is excreted in expired air; and
(b) determining the ratio of labeled CO 2 amount to unlabeled CO 2 amount contained in expired air or the ratio of labeled CO 2 amount to total CO 2 amount contained in expired air.
2. A method for measuring insulin resistance of a test subject, comprising
determining an area under a Δ-labeled C(‰)-expired air collection time t curve, based on a method having steps (a) and (b) below (herein referred to as “AUCt[labeled C-fatty acid]”),
determining a blood glucose level of the test subject,
using a value obtained by dividing the reciprocal of the blood glucose level (1/blood glucose level) of the test subject by the AUCt[labeled C-fatty acid] (1/blood glucose level/AUCt[labeled C-fatty acid]) as an index for the sugar/fatty acid combustion ratio,
determining a first index of the sugar/fatty acid combustion ratio under a fasting condition and a second index of the sugar/fatty acid combustion ratio under a feeding condition for the test subject, and
determining a difference between the first index and the second index, wherein the test subject's insulin resistance is measured,
wherein
the method in which AUCt[labeled C-fatty acid] is determined has the steps of:
(a) intravenously administering a composition comprising a C 12-38 fatty acid or a salt thereof labeled with at least one isotope of carbon to a test subject and collecting expired air, so that the C 12-38 fatty acid or a salt thereof is converted in the body into labeled carbon dioxide that is excreted in expired air; and
(b) determining the ratio of labeled CO 2 amount to unlabeled CO 2 amount contained in expired air or the ratio of labeled CO 2 amount to total CO 2 amount contained in expired air.
3. A method for measuring insulin resistance of a test subject, comprising
determining Ct[labeled C-fatty acid] (t=1-30 min) of Δ-labeled C(‰), based on a method having steps (a) and (b) below,
determining a blood glucose level of the test subject,
using a value obtained by dividing the reciprocal of the blood glucose level (1/blood glucose level) of the test subject by Ct[labeled C-fatty acid] (t=1-30 min) ([1/blood glucose level]/Ct[labeled C-fatty acid] (t=1-30 min)), as an index for the sugar/fatty acid combustion ratio,
determining a first index of the sugar/fatty acid combustion ratio under a fasting condition and a second index of the sugar/fatty acid combustion ratio under a feeding condition for the test subject, and
determining a difference between the first index and the second index, wherein the test subject's insulin is measured,
wherein
the method in which Ct[labeled C-fatty acid] (t=1-30 min) is determined has the steps of:
(a) intravenously administering a composition comprising a C 12-38 fatty acid or a salt thereof labeled with at least one isotope of carbon to a test subject and collecting expired air at least one time point between 1 to 30 minutes after the composition administration, so that the C 12-38 fatty acid or a salt thereof is converted in the body into labeled carbon dioxide that is excreted in expired air; and
(b) determining the ratio of labeled CO 2 amount to unlabeled CO 2 amount contained in expired air or the ratio of labeled CO 2 amount to total CO 2 amount contained in expired air.
4. The method according to any one of claims 1 to 3 , wherein the isotope of C 12-38 fatty acid is 13 C.
5. The method according to any one of claims 1 to 3 , wherein the C 12-38 fatty acid is a C 12-18 saturated fatty acid or a C 18 unsaturated fatty acid.
6. The method according to any one of claims 1 to 3 , wherein the C 12-38 fatty acid is at least one member selected from the group consisting of lauric acid, myristic acid, pentadecylic acid, stearic acid, oleic acid, and palmitic acid.
7. The method according to any one of claims 1 to 3 , wherein the test subject has at least one condition selected from the group consisting of borderline diabetes, type II diabetes, liver cirrhosis, non-alcoholic steatohepatitis, and non-alcoholic fatty liver disease.
8. The method according to any one of claims 1 to 3 , further comprising: comparing a difference between the first index and the second index obtained from the test subject (test subject value) to a difference between the first index and the second index obtained from a healthy subject having a normal insulin resistance (control value), wherein when the test subject value is smaller than the control value, the insulin sensitivity of the test subject is decreased (insulin resistance).